We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Figures underline challenge the health service faces in returning to pre-coronavirus care provision
Prime minister sets out vision for ‘levelling up’ but critics point to notable omissions
Planned legislation includes proposal to require voters to provide proof of identity
UK government bonds fall in price as concerns over Scottish independence referendum fade
Declining infection rates mean potential risks from jab may outweigh dangers of disease
UK ministers split on whether homes should be included in assessing eligibility for means-tested care
UK government’s new legislative programme is due to contain more than 25 bills
Health service’s performance has become a central issue in the devolved nation’s assembly election on May 6
Public Health England releases most comprehensive research yet into effect of immunisation
Forced co-operation during the pandemic has taught both sides how they can operate in a mutually beneficial way
Creation of task force by UK government welcomed but no trials have delivered solutions
Antivirals task force will seek to develop medicines people can take at home
Manufacturers consider withdrawing up to 90% of medicines they currently send to region
CEO Emma Walmsley under scrutiny as British drugmaker’s cupboard looks increasingly bare
But Joint Committee on Vaccination and Immunisation advises against using AstraZeneca shot
Crisis exposes longstanding grievances about pay and conditions in the industry
Activist group’s investment comes as UK drugmaker’s performance lags behind rivals
Rapid consultation begun by health department after findings that not enough institutions reaching safe jab threshold
Prevalence highest in 35-69 age group, women, those living in deprived areas and healthcare workers
Drugmaker will ‘fill and finish’ as-yet-unapproved jabs as talks continue over EU export controls
The AstraZeneca chief is caught in the crossfire over a Covid-19 jab that could save millions
Questions mount over whether Soriot’s dash and drive, which enthral investors, have resulted in missteps
Prime minister under pressure to put better deal on the table after Scottish government offers NHS staff a 4% increase
Dispute with independent scientists overseeing US trial is latest blow to tortured rollout
UK prime minister spoke to European Commission head as Britain faces shortfall of jabs
International Edition
